Examine the Psychosocial Impacts of Covid-19 Pandemic.

Sponsor
University of Otago (Other)
Overall Status
Recruiting
CT.gov ID
NCT05052333
Collaborator
International Islamic University, Islamabad (Other), Universitas Ahmad Dahlan (Other), Gadjah Mada University (Other), Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq (Other), Al-Mustansiriyah University (Other), Hasan Kalyoncu University (Other), University of Washington (Other), University of Malaya (Other)
4,000
9
25
444.4
17.8

Study Details

Study Description

Brief Summary

This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Bangladesh, Indonesia, Iraq, Malaysia, Pakistan, Somalia, and Turkey). The data will be obtained on the measures of wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and pandemic-related stress (Covid Psychosocial Impacts Scale). Depending on the context, the data will be collected employing either a unilingual (in native language) or bilingual online survey (with English as a second language) from 500 participants (aged 18 and above) in each of the seven locations using non-probability convenient sampling. Where applicable in some countries (Malaysia, Somalia, Turkey), a follow-up survey will be repeated in the same cohort, which will provide a comparable data set longitudinally. The findings will enable us to examine the psychosocial impacts of COVID-19; validate the translations of the CPIS and standardized measures; and determine the trajectory of study variables with pandemic exposure.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    4000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    An International Study Examining the Psychosocial Impacts of Covid-19 Pandemic.
    Actual Study Start Date :
    Dec 1, 2021
    Anticipated Primary Completion Date :
    Dec 31, 2022
    Anticipated Study Completion Date :
    Dec 31, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Examining the psychosocial impacts of Covid-19 in Pakistan.

    This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off bilingual (Urdu-English) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.

    Examining the psychosocial impacts of Covid-19 in Iraq.

    This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off bilingual (Arabic-English) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.

    Examining the psychosocial impacts of Covid-19 in Turkey.

    This is exploratory research and data will be obtained on a set of measures (N=500) using a unilingual (Turkish) survey with longitudinal assessment after 12 months of the initial assessment. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.

    Examining the psychosocial impacts of Covid-19 in Bangladesh.

    This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off unilingual (Bangla) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.

    Examining the psychosocial impacts of Covid-19 in Malaysia.

    This is exploratory research and data will be obtained on a set of measures (N=500) using a bilingual (Malay-English) survey. Data will be obtained longitudinally after 12 months of initial assessment. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.

    Examining the psychosocial impacts of Covid-19 in Indonesia.

    This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off unilingual (Indonesian) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.

    Examining the psychosocial impacts of Covid-19 in Somalia.

    This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off bilingual (Somalia-English) longitudinally. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.

    Outcome Measures

    Primary Outcome Measures

    1. Examining the psychosocial impacts of the COVID-19 pandemic. [The time it takes to perform the initial assessment varies, but it usually takes about 9 months. The follow-up longitudinal assessments (Malaysia, Somalia, Turkey) will take an average of two years to complete once the study is completed.]

      To explore the psychosocial impacts of the Covid-19 pandemic on self-report questionnaires of wellbeing (WHO-5), psychological distress (K10), post-traumatic stress (PCL-5), post-traumatic growth (PTGI), and pandemic-related stress (CPIS) in several low-resource countries. The data will be collected employing a unilingual (Bangladesh, Indonesia, Turkey) or bilingual (Iraq, Malaysia, Pakistan, Somalia) survey. Where applicable, a follow-up survey will be repeated longitudinally (Malaysia, Somalia, Turkey). With-in-subjects and between-subjects designs together with exploratory regression analyses will be employed to characterize this outcome.

    Other Outcome Measures

    1. Analyzing the psychometric properties of the translations of the newly developed CPIS and other standardized measures. [The time it takes to perform the initial assessment varies, but it usually takes about 9 months. The follow-up longitudinal assessments (Malaysia, Turkey, Somalia) will take an average of two years to complete.]

      The findings will give psychometric information on the translations and suitability of use of the newly developed CPIS and other standardized questionnaires (K10, WHO-5, PCL-5, PTGI) in several low-resource countries. The findings will help determine the quality of translations and their appropriateness for usage in the target population. The data will be collected employing a unilingual (Bangladesh, Indonesia, Turkey) or bilingual (Iraq, Malaysia, Pakistan, Somalia) survey. Where applicable, a follow-up survey will be repeated longitudinally (Malaysia, Somalia, Turkey). The metric used to characterize this outcome involves reliability (internal consistency, test-retest reliability) and validity (convergent, discriminant) analyses.

    2. Analyzing the longitudinal trajectory of the psychosocial impacts of the Covid-19 pandemic. [The time to complete the study can vary but it will be completed in an average of 2 years.]

      The data will be obtained longitudinally in some countries to understand the trajectory of psychosocial impacts and to examine the degree of changes over time. The data will be collected employing a unilingual (Turkey) or bilingual (Malaysia, Somalia) survey and it will comprise of several self-report questionnaires of wellbeing (WHO-5), psychological distress (K10), post-traumatic stress (PCL-5), post-traumatic growth (PTGI), and newly developed measures of pandemic-related stress (CPIS). A follow-up survey will be repeated longitudinally in the same cohort. The metric used to characterize this outcome involves tabular and graphical measures and the use of linear mixed model analysis.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Aged 18 and above

    • Currently residing in the country of interest.

    • Additional inclusion criterion applies to bilingual studies; which is having English as a second language.

    Exclusion Criteria:
    • Aged below 18 years.

    • Not residing in the country of interest.

    • Additional exclusion criterion applies to bilingual studies; which is not having English as a second language.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Washington Seattle Washington United States 98195-1525
    2 Universitas Ahmad Dahlan Yogyakarta Indonesia
    3 Universitas Gadjah Mada Yogyakarta Indonesia
    4 Ibn Sina University of Medical and Pharmaceutical Sciences Baghdad Iraq
    5 Mustansiriyah University Baghdad Iraq
    6 Universiti Malaya Kuala Lumpur Malaysia
    7 International Islamic University Islamabad Pakistan 44000
    8 Quaid-i-Azam University Islamabad Pakistan 44000
    9 Hasan Kalyoncu Üniversitesi Gaziantep Turkey

    Sponsors and Collaborators

    • University of Otago
    • International Islamic University, Islamabad
    • Universitas Ahmad Dahlan
    • Gadjah Mada University
    • Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq
    • Al-Mustansiriyah University
    • Hasan Kalyoncu University
    • University of Washington
    • University of Malaya

    Investigators

    • Principal Investigator: Caroline Bell, MD, University of Otago Christchurch, New Zealand
    • Principal Investigator: Sandila Tanveer, PhD, University of Otago Christchurch, New Zealand
    • Principal Investigator: Ruqayya Sulaiman-Hill, PhD, University of Otago Christchurch, New Zealand
    • Study Director: Richard Porter, MRCPsych, University of Otago Christchurch, New Zealand
    • Principal Investigator: Joseph Boden, PhD, University of Otago Christchurch, New Zealand
    • Principal Investigator: Ben Beaglehole, FRANZCP, University of Otago Christchurch, New Zealand
    • Principal Investigator: Shaystah Dean, PhD, University of Otago Wellington, New Zealand
    • Principal Investigator: Philip Schluter, PhD, University of Canterbury, New Zealand

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Sandila Tanveer, Assistant Research Fellow, University of Otago
    ClinicalTrials.gov Identifier:
    NCT05052333
    Other Study ID Numbers:
    • UOtago
    First Posted:
    Sep 22, 2021
    Last Update Posted:
    Jul 27, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Sandila Tanveer, Assistant Research Fellow, University of Otago
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 27, 2022